Gelesis Holdings, Inc. (GLSHQ) Financials

GLSHQ Assets vs Liabilities
DateAssetsLiabilities
June 30, 2023 95.9 million 114.5 million
March 31, 2023 98.8 million 112.6 million
Dec. 31, 2022 103.3 million 115.8 million
Sept. 30, 2022 130.5 million 123.6 million

GLSHQ Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2023 599000 2.4 million
March 31, 2023 -8.9 million 2.1 million
Dec. 31, 2022 -16.9 million 3.2 million
Sept. 30, 2022 -25.1 million 4.6 million

GLSHQ Net Income

No data available :(

GLSHQ Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2023 7.9 million 27.3 million 1.2 million
March 31, 2023 3.1 million 26.0 million 1.4 million
Dec. 31, 2022 7.4 million 25.3 million 1.6 million
Sept. 30, 2022 24.8 million 26.7 million 1.7 million

GLSHQ Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2023 73.3 million
March 31, 2023 73.3 million
Dec. 31, 2022 73.2 million
Sept. 30, 2022 72.8 million

GLSHQ Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2023 18000 2.6 million 7.5 million 649000
March 31, 2023 224000 3.6 million 8.3 million 2.3 million
Dec. 31, 2022 647000 2.3 million 11.9 million 6.2 million
Sept. 30, 2022 3.4 million 3.4 million 17.0 million 7.3 million

GLSHQ Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2023 1.1 million 498000
March 31, 2023 1.8 million 1.2 million
Dec. 31, 2022 2.6 million 14.2 million
Sept. 30, 2022 6.7 million 3.6 million

GLSHQ

Price: $0

52 week price:
0.00
0.01

Earnings Per Share: -0.70 USD

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 7334

Links: